Yazar "Ongen, G." seçeneğine göre listele
Listeleniyor 1 - 5 / 5
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe THE COST-EFFECTIVENESS OF RIVAROXABAN COMPARED TO ENOXAPARIN PLUS ADJUSTED-DOSE WARFARIN FOR THE TREATMENT OF DEEP VENOUS THROMBOSIS (DVT) IN TURKEY(Elsevier Science Inc, 2013) Parali, E.; Ozdemir, O.; Bozkurt, K.; Demir, M.; Ince, B.; Kultursay, H.; Ongen, G.[Abstract Not Available]Öğe THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF) IN TURKEY(Elsevier Science Inc, 2013) Marmarali, B.; Ozdemir, O.; Bozkurt, K.; Demir, M.; Ince, B.; Kultursay, H.; Ongen, G.[Abstract Not Available]Öğe THE COST-OF-DISEASE OF DEEP VENOUS THROMBOSIS AND ITS SHORT- AND LONG-TERM CLINICAL CONSEQUENCES IN TURKEY: AN EXPERT PANEL APPROACH FOR ESTIMATION OF COSTS(Elsevier Science Inc, 2013) Deger, C.; Ozdemir, O.; Bozkurt, K.; Demir, M.; Ince, B.; Kultursay, H.; Ongen, G.[Abstract Not Available]Öğe THE COST-OF-DISEASE OF THROMBOEMBOLIC AND HEMORRHAGIC COMPLICATIONS ASSOCIATED WITH ATRIAL FIBRILLATION AND ITS TREATMENT IN TURKEY: AN EXPERT PANEL APPROACH FOR ESTIMATION OF COSTS(Elsevier Science Inc, 2013) Deger, C.; Ozdemir, O.; Bozkurt, K.; Demir, M.; Ince, B.; Kultursay, H.; Ongen, G.[Abstract Not Available]Öğe Epidemiological features of Turkish patients with sarcoidosis(W B Saunders Co Ltd, 2009) Musellim, B.; Kumbasar, O. O.; Ongen, G.; Cetinkaya, E.; Turker, H.; Uzaslan, E.; Yenturk, E.Epidemiological characteristics of sarcoidosis differ according to geographical distribution. The aim of our study was to disclose epidemiological characteristics in our country. The data was collected from investigators, who sent information on newly-diagnosed patients via internet. In 2 years 198 female and 95 mate patients were enrolled to the study (f/m:2.08). Mean age of patients was 44 +/- 13 years (17-90). Mean age of mate patients was 38 12 while mean age of female patients was 48 13 (p < 0.001). 73.4% of patients were nonsmokers (85.4% of females; 48.4% of mates; (p < 0.001)). About 50% of our 293 patients were housewives. Familial sarcoidosis was found in 3 patients' first degree relatives. Estimated annual incidence of sarcoidosis for Turkey was calculated as 4 per 100,000 person. According to our study, 2/3 of sarcoidosis patients were women; mean age of patients was 45 and the disease began 10 years later in female patients. 80% of patients were nonsmokers; negative relation between sarcoidosis and smoking was evident especially in women. Familial sarcoidosis frequency was lower compared to other studies in the literature. There was no occupational exposure history in our patients. Our incidence rate, is similar with the results of other European studies. (C) 2008 Elsevier Ltd. All rights reserved.
